Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Zenith Epigenetics Announces Collaboration with ... BMS = Bristol Myers Squibb = deep pockets

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications

BearDownAZ

Oct 05, 2020 08:24AM

Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications

noretreat

Oct 05, 2020 09:50AM

Re: Zenith Epigenetics Announces Collaboration with ... BMS = Bristol Myers Squibb = deep pockets

Payzone

Oct 05, 2020 12:27PM

Telepanel

Rank: Treasurer [?]

Points: 1140 [?]

Votes: 22 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics Announces Collaboration with ... BMS = Bristol Myers Squibb = deep pockets

in response to

Re: Zenith Epigenetics Announces Collaboration with ... BMS = Bristol Myers Squibb = deep pockets

Payzone

posted on Oct 05, 2020 12:34PM

Nice PR except no details,such as who pays what.They have still not told us wether the 2nd tranche of the 5 mill was done.No plan for liquidity etc

2 Recommendations

Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications

fuzzyjr

Oct 05, 2020 03:01PM

Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications

KOO-KOO2

Oct 05, 2020 04:43PM

Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications

fuzzyjr

Oct 05, 2020 05:10PM

Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications

noretreat

Oct 05, 2020 06:27PM

Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications

SanFrancisco99

Oct 05, 2020 06:41PM

Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications

Toinv

Oct 05, 2020 07:08PM

Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications